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As of now, hepatotropic viruses are classified into hepa-
titis A (HAV), B (HBV), C (HCV), D (HDV), E (HEV) and
possibly G (HGV/GB virus-C) [1]. HAV and HEV are
transmitted mainly via the enteral route, whereas HBV,
HCV, HDV and HGV are transmitted mainly via the
parenteral route [2]. No chronicity occurs following
acute HAV or HEV infection, but a chronic carrier state
does exist for HBV, HCV, HDV and HGV infections,
especially in those infected during infancy or early
childhood [2]. The importance of perinatal infection
and subsequent serious consequences warrant a careful
understanding of the perinatal routes of infection and
the search for effective interventions.
Perinatal transmission of hepatitis viruses can be
determined by the timing of infection and infectious
routes during pregnancy, delivery and parturition. The
former can be divided into prepartum (intrauterine),
intrapartum and postpartum periods, while the latter
can be divided into infection of germ cells, transplacental
leakage of maternal blood, birth canal infection and
infection through breast-feeding (Figure).
HAV and HEV
Although the frequency is low, perinatal transmission of
HAV does occur [3]. Although no prepartum (intra-
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uterine) infection has been reported, HAV infection can
take place during the intrapartum or postpartum periods
[3]. Perinatal HAV transmission usually results from
viremic maternal blood entering the fetal circulation
because of placental abruption during labor. Alterna-
tively, transmission may occur as a result of exposure to
maternal feces during birth [3]. In contrast, perinatal
HEV transmission can occur during the prepartum,
intrapartum and postpartum periods [4,5]. In one
report, six of eight infants vaginally delivered from HEV-
infected mothers were infected with HEV, and HEV RNA
was detected in cord or birth blood samples in five of the
infants [4]. In addition, abortions and intrauterine
deaths are common in pregnant women suffering from
acute hepatitis E [4].
HBV and HDV
Due to the high prevalence of HBV carrier mothers in
Asian countries [2,6], perinatal transmission is the main
route of perpetuating HBV infection for generations in
these areas before the launch of immunoprophylaxis
administered to newborns of HBV carrier mothers [7,
8]. The routes of perinatal HBV transmission include
intrauterine (prepartum) and birth canal (intrapartum)
infection. HBV infection from breast-feeding (postpartum)
is unlikely, especially in newborns receiving immuno-
prophylaxis [9-11].
The incidence of intrauterine infection of fetuses
with HBV is low and may account for only 2–3% of pe-
rinatal HBV transmission [12]. Some may be caused by
HBV infection of germ cells (vertical transmission) [13],
but most are due to transplacental leakage of HBeAg-
positive maternal blood, which is evidenced clinically by
the occurrence of uterine contractions in cases of
threatened abortion and/or threatened preterm labor
in these mothers [14]. The breakdown of the placental
barrier may result in leakage of maternal blood into the
fetal circulation. Thus, prepartum administration of
hepatitis B immunoglobulin (HBIG) to the fetus under
ultrasound guidance may be a remedy in such cases
[14], since there is currently no effective measures to
protect the newborn from in utero infection. The failure
of current immunoprophylaxis against perinatal HBV
transmission may result from intrauterine infection, in-
adequate HBIG dose to completely neutralize HBV in fetal
circulation from carrier mothers during the prepartum
or intrapartum periods, and non-responsiveness to
hepatitis B vaccines [15].
In addition to viral virulence, the efficiency of viral
infection depends on both the inoculum dose and the
routes of transmission [16]. Also, the incubation period
of hepatitis B is inversely proportional to the inoculum
dose of HBV. For perinatal HBV transmission, the
inoculum dose of HBV from the carrier mother to the
fetus is an important factor that determines the efficiency
of HBV infection. HBV usually infects the fetus through
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Figure. Mechanisms of perinatal transmission of hepatitis viruses. The routes of infection are classified into intrauterine, birth
canal, and mother-to-infant. The timing of infection is divided into prepartum, intrapartum, and postpartum. The definite items
of perinatal transmission consist of infection of germ cells, transplacental leakage of maternal blood, maternal-fetal micro-
transfusion, and breast-feeding.
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prepartum or intrapartum transplacental leakage, which
are much more efficient than through the birth canal.
Thus, HBeAg-positive carrier mothers, especially those
who are positive for HBV DNA by hybridization assays,
can induce perinatal HBV transmission more easily in
the case of transplacental leakage of maternal blood or
in the absence of immunoprophylaxis for newborns [14,
15]. Furthermore, the transplacental passage of HBeAg
can induce immune tolerance to HBV in newborns of
HBeAg-positive carrier mothers, which facilitates the
establishment of a chronic state following perinatal
HBV infection [17].
HDV is a satellite virus and needs the help of HBV
for virion assembly. There is no correlation between peri-
natal HBV transmission and the presence of HDV in
HBV carrier mothers [18].
HCV
HCV is also a blood-borne virus and the mechanisms
involved in perinatal HCV transmission are very similar
to those of HBV. However, the virus titers of HCV are
usually much lower than HBV, as reflected by the lower
prevalence rate of HCV carriers and the lower frequency
of perinatal HCV transmission [19–22]. To the best of
our knowledge, neither HCV intrauterine infection nor
HCV infection of germ cells have been reported [19,22],
although transplacental leakage of HCV-infected ma-
ternal blood can occur, just as in HBV carrier mothers.
Plausible explanations may be that the viral titers of
HCV are usually lower than those of HBV, or the virulence
of HCV may be weaker than that of HBV. Intrapartum
perinatal HCV transmission can occur, and the frequency
may be less than 10% [20,21]. The major determinants
of perinatal HCV transmission include high-titer ma-
ternal viremia [19,22] and mode of delivery [22,23].
Among the various modes of delivery, elective cesarean
section has the least microtransfusion from mother to
fetus [23,24]; it may be an effective way to avoid peri-
natal HCV transmission from high-titer HCV-infected
mothers to their offspring in the absence of immuno-
prophylaxis against HCV infection [25,26]. HCV-infected
mothers breast-feeding their newborns is safe [27]
because: 1) the amount of HCV in the milk is low and it
follows an enteral route; 2) the integrity of the oral and
gastrointestinal mucosa of the infant may effectively
prevent HCV infection via the enteral route; 3) the small
amount of HCV present in the milk may be easily
inactivated in the gastrointestinal tract; 4) HCV may be
neutralized by antibodies or other proteins in the milk
[16]. However, if the HCV-infected parturient has
mastitis or mammary abscess, then breast-feeding
should be prohibited because a large amount of maternal
blood may leak into the breast milk.
HGV/GB Virus-C
Although HGV may not be a hepatotropic virus and cau-
ses no significant liver disease [28], perinatal HGV trans-
mission does occur, as do HBV and HCV transmission.
However, the frequency of perinatal HGV transmission
is much higher than for HBV and HCV, ranging from 50–
70% [29,30]. As in adults, HGV-infected infants show
no overt hepatic dysfunction [28-30]. High-titer
maternal viremia and mode of delivery also play major
roles in causing perinatal HGV transmission [29]. These
facts suggest that intrapartum infection is the main
route of perinatal HGV transmission. No intrauterine
HGV infection has been reported in the literature, same
as for HCV. The reasons might be that HGV cannot infect
germ cells or that its virulence is weak and it is thus
incapable of inducing prepartum HGV infection. The
safety of breast-feeding in HGV-infected mothers deserves
further study.
Conclusions
Perinatal transmission of enteral hepatitis viruses (HAV
and HEV) can occur during the intrapartum and post-
partum periods, whereas transmission of the blood-borne
hepatitis viruses (HBV, HCV and possibly HGV) mainly
occurs during delivery (intrapartum). Both high-titer
maternal viremia and mode of delivery are important
determinants of the perinatal transmission of hepatitis
viruses. Additionally, only HBV can infect germ cells and
cause intrauterine infection. Elective cesarean section
has the least microtransfusion from mother to fetus in
various modes of delivery, and it may be used to prevent
intrapartum HCV infection since immunoprophylaxis
against this virus is unavailable. In addition, it is impor-
tant to reduce the maternal viral titer for hepatitis virus
carriers at least 6 months before the planned pregnancy,
i.e. such as by using combination therapy with interferon
and other antiviral agents.
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